Impact of quality risk management process in pharmaceutical industry to curtail the non conformity

1Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

Risk is intertwined with every drug product in a market. This article’s intent is to provide ground rule and praxis of different tools for quality risk management (QRM) in various aspects of pharmaceutical science. QRM comprises of tools and processes which helps in establishing objectives. Hence they are also known as Enablers. Enablers help in risk mitigation of product quality throughout a lifecycle in such a way that benefit outweighs the risk. The key properties of Enablers or QRM, i.e., attempts made, solemnness and records shall be compatible with risk scale. The Enablers accomplishment gives recognized, obvious and steps of Enabler process produced by regeneratable methods which is based on customary comprehension to evaluate feasibility, ability to find out risk prejudice. The QRM or Enabler tools can assist the manufacturing company and regulatory bodies to scrutinize, handle, notify, and inspect the risk.

Cite

CITATION STYLE

APA

Sharma, A., Jeyaprakash, R. M., Bora, R., & Chandra, A. (2020, January 1). Impact of quality risk management process in pharmaceutical industry to curtail the non conformity. International Journal of Pharmaceutical Quality Assurance. International Journal of Pharmaceutical Quality Assurance. https://doi.org/10.25258/ijpqa.11.1.28

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free